VC-backed Nightstar files for IPO
London-based Nightstar, a retinal gene therapy company, has filed for an IPO. The number of shares that will be sold as well as the stock's pricing terms have yet to be set. Nightstar is planning on listing the stock on the NASDAQ under the ticker symbol "NITE." Jefferies LLC, Leerink Partners LLC and BMO Capital Markets Corp are the lead underwriters. Nightstar is backed by Wellington Management Company, Redmile Group, Syncona and New Enterprise Associates.
1 September 2017•2 mins read
